Related Experiment Video
Updated: Apr 19, 2026

Quantitative Autonomic Testing
Published on: July 19, 2011
Does non-pharmacological treatment affect outcomes in dysautonomic syndromes?
1Cardiac Arrhythmias Unit, Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil. denise.hachul@gmail.com.
Abstract:
Dysautonomic syndromes are very common clinical conditions with different presentations and a wide spectrum of mechanisms. Many non-pharmacological and pharmacological interventions have been recommended to treat dysautonomic patients along these years, but the majority of them were not supported by multicenter controlled trials. General measures, like water drinking and salt intake, avoiding triggers and recognizing prodromal symptoms, as well as performing orthostatic training and physical conditioning are commonly able to improve symptoms and avoid syncope and falls. In this article, we will explore why and how such measures are applied to treat patients with dysautonomic syndromes, based on the physiopathology of these disorders.
More Related Videos
06:51Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
Published on: July 29, 2016
14:09Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
Published on: March 21, 2013
Related Concept Videos
Dysrhythmias VII: Nursing Management of Dysrhythmias
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Dysrhythmias VI: Management of Dysrhythmias
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...